SGA、MNA和NRS2002评估失代偿期肝硬化患者营养状态应用价值分析*

doi:10.3969/j.issn.1672-5069.2020.01.020

摘要/Abstract

摘要： 目的研究主观全面评定法(SGA)、简易营养评价法(MNA)和营养风险筛查2002(NRS2002)用于失代偿期肝硬化患者营养评估的应用价值。方法 2017年1月～2018年1月我院收治的98例失代偿期肝硬化患者,采用SGA法、MNA法和NRS2002法行营养风险筛查。采用Kappa一致性检验评估SGA、MNA和NRS2002对患者营养不良评价的一致性。结果 MNA法判定患者轻中度营养不良发生率为36.7%,重度营养不良发生率为30.6%,SGA法判定患者轻中度营养不良发生率为30.6%,重度营养不良发生率为2.0%,NRS2002法判定患者轻中度营养不良发生率为25.5%,重度营养不良发生率为15.3%;SGA法与MNA法评定结果一致性检验的Kappa值为0.344,差异显著(P＜0.05),SGA法与NRS2002法评定结果一致性检验的Kappa值为0.476,存在显著性差异(P＜0.05),MNA法与NRS2002法评定结果一致性检验的Kappa值为0.463,也差异显著(P＜0.05)。结论现行的营养评估方法在评估失代偿期肝硬化患者营养状况时,可能存在显著性差异,还需要针对这类人群设计合理、可行的方法评估,以正确地指导临床治疗。

关键词: 肝硬化, 营养不良, 主观全面评定法, 简易营养评价法, 营养风险筛查2002

Abstract: Objective The purpose of this study was to investigate the application of subjective comprehensive assessment (SGA), simple nutritional assessment (MNA) and nutritional risk screening 2002 (NRS2002) in nutritional assessment of patients with decompensated cirrhosis. Methods 98 patients with decompensated liver cirrhosis were admitted to our hospital between January 2017 and January 2018, and the nutritional risk were screened by SGA, MNA and NRS2002 in all the patients. The consistency of the three methods was compared byKappa value. Results The incidence of mild to moderatemalnutrition by MNA was 36.7% and that of severe malnutrition was 30.6%, the incidence of mild to moderate malnutrition by SGA was 30.6% and that of severe malnutrition 2.0%, and the incidence of mild to moderate malnutrition by NRS2002 was 25.5% and that of severe malnutrition was 15.3%; the Kappa value was 0.344(P＜0.05) as regard to the consistence of SGA and MNA, the Kappa valve was 0.476 (P＜0.05) as regard to the consistence of SGA and NRS2002, and the Kappa value was 0.463(P＜0.05) as the consistence of evaluation by MNA and NRS2002 were compared. Conclusion The differences of malnutrition status assessed by different methods in our series might be great, which hints further investigation needed in the future for Objective evaluation in this setting.

Key words: Liver cirrhosis, Malnutrition, Subjective global assessment, Mini nutritional assessment, Nutritional risk screen2002

杨晓玲, 张素梅. SGA、MNA和NRS2002评估失代偿期肝硬化患者营养状态应用价值分析^*[J]. 实用肝脏病杂志, 2020, 23(1): 70-73.

Yang Xiaoling, Zhang Sumei. Application of SGA, MNA and NRS2002 in nutritional assessment of patients withdecompensated liver cirrhosis[J]. Journal of Practical Hepatology, 2020, 23(1): 70-73.

参考文献

[1] 王治冲, 宋风斌. 失代偿期乙型肝炎肝硬化患者营养状况分析. 实用肝脏病杂志, 2017, 20(2):236-237.
[2] Harrison PM. Management of patients with decompensated cirrhosis.Clin Med, 2015, 15(2):201-203.
[3] Brandon P, Andrew L, George C, et al. Optimizing the nutritional support of adult patients in the setting of cirrhosis.Nutrients, 2017, 9(10):1114-1124.
[4] Zhou J, Wang M, Wang H, et al. Comparison of two nutrition assessment tools in surgical elderly inpatients in Northern China. Nutr J, 2015, 14(1):68-75.
[5] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19(3):Ⅴ-ⅩⅩⅢ.
[6] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 酒精性肝病诊疗指南. 实用肝脏病杂志, 2007, 10(1):74-76.
[7] 于康, 临床营养师速查手册. 北京:科学技术文献出版社. 2001:148-148.
[8] 袁华财,张甜甜,郭冬梅,等. 微型营养评价量表在社区老年人群中的信效度评价. 山东大学学报(医学版), 2018, 56(9):82-87.
[9] Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr, 2003, 22(3):321-336.[10] Nguyen T. Comparison of current practice and best practice guidelines for the nutritional management of patients with liver cirrhosis: An Australian survey of dietitians in clinical practice. Nutr Diet, 2015, 72(3):247-253.
[11] Booi AN , Menendez J , Norton H J , et al. Validation of a screening tool to identify undernutrition in ambulatory patients with liver cirrhosis. Nutr Clin Pract, 2015, 30(5):683-689.
[12] Slee A , Birch D , Stokoe D . A comparison of the malnutrition screening tools, MUST, MNA and bioelectrical impedance assessment in frail older hospital patients. Clin Nutr, 2015, 34(2):296-301.
[13] Arslan M , Soylu M , Kaner G , et al. Evaluation of malnutrition detected with the Nutritional Risk Screening 2002 (NRS-2002) and the quality of life in hospitalized patients with chronic obstructive pulmonary disease.Hippokratia, 2016, 20(2):147-152.
[14] Giestas S, Giestas A, Agostinho C, et al. P0196 : Nutritional status evaluation of nonhospitalized patients with alcoholic liver cirrhosis. J Hepatol, 2015, 62(2):S378-S379.
[15] Menta PL, Correia MI, Vidigal PV, et al. Nutrition status of patients with chronic hepatitis B or C.Nutr Clin Pract, 2015, 30(2):290-296.
[16] Schütte K, Tippelt B, Schulz C, et al. Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC). Clin Nutr, 2015, 34(6):1122-1127.
[17] Abbott J, Teleni L, Mckavanagh D, et al. Patient-generated subjective global assessment short form (PG-SGA SF) is a valid screening tool in chemotherapy outpatients. Support Care Cancer, 2016, 24(9):3883-3887.
[18] Donini LM , Poggiogalle E ,Molfino A , et al. Mini-nutritional assessment, malnutrition universal screening tool, and nutrition risk screening tool for the nutritional evaluation of older nursing home residents. J Am Med Dir Assoc, 2016, 17(10):959-968.
[19] Zhiying Z , Suzette P , Menghua L , et al. Evaluation of blood biomarkers associated with risk of malnutrition in older adults: a systematic review and meta-analysis. Nutrients, 2017, 9(8):829-848.
[20] Dubhashi SP, Kayal A. Preoperative nutritional assessment in elderly cancer patients undergoing elective surgery: MNA or PG-SGA?Indian J Surg, 2015, 77(2):232-235.

SGA、MNA和NRS2002评估失代偿期肝硬化患者营养状态应用价值分析^*

Application of SGA, MNA and NRS2002 in nutritional assessment of patients withdecompensated liver cirrhosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	徐小元. 解读肝硬化诊治指南难点与新颖之处[J]. 实用肝脏病杂志, 2020, 23(1): 4-6.
[2]	王晶晶, 李春涛, 周卫真. 失代偿期乙型肝炎肝硬化患者尿液视黄醇结合蛋白水平及其临床意义探讨^*[J]. 实用肝脏病杂志, 2020, 23(1): 74-77.
[3]	杨慧玲, 刘小静, 何英利, 杜粉静, 叶峰. 失代偿期乙型肝炎肝硬化患者发生医院感染临床特点及危险因素分析^*[J]. 实用肝脏病杂志, 2020, 23(1): 78-81.
[4]	赵平, 黎涛, 谢吉良, 郑波. 早期抗凝干预用于经颈静脉肝内门体静脉支架分流术联合PSE治疗肝硬化患者价值探讨^*[J]. 实用肝脏病杂志, 2020, 23(1): 82-85.
[5]	张冰, 解学军. 酒精性肝硬化患者血CTLA-4和PNPLA3基因多态性及其临床意义分析^*[J]. 实用肝脏病杂志, 2020, 23(1): 86-89.
[6]	庄莹, 林志辉. 肝硬化并发门静脉血栓临床表现和诊断进展[J]. 实用肝脏病杂志, 2019, 22(6): 765-767.
[7]	杨才勇, 陈娜, 李奎, 江自成, 卜蓉蓉. 慢性丙型肝炎和丙型肝炎肝硬化患者外周血Treg和Th17水平变化临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(6): 868-871.
[8]	朱娅鸽, 刘锦峰. 丁二磺酸腺苷蛋氨酸联合复方甘草酸苷治疗酒精性肝硬化患者疗效及其对血清BGP水平的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 872-875.
[9]	武丹, 马向鹰. 非酒精性脂肪性肝病肝硬化患者胰岛素抵抗水平与颈动脉硬化程度和左心室功能研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 876-879.
[10]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[11]	刘李, 杨烈, 陈海洋, 何承俊, 王建宇, 陈廷昊. 肝硬化门静脉高压症并发脾动脉盗血综合征患者脾切除联合贲门周围血管离断术后门脉血流动力学的变化^*[J]. 实用肝脏病杂志, 2019, 22(6): 884-887.
[12]	何志安, 余丽萍, 赖江琼, 黄思付. ARFI评估肝硬化并发食管胃底静脉曲张患者出血和门静脉血栓的价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 888-891.
[13]	中华医学会肝病学分会, 中华医学会消化病学分会. 终末期肝病临床营养指南[J]. 实用肝脏病杂志, 2019, 22(5): 624-635.
[14]	王月圆, 王燕, 张丹丹. 奥曲肽辅助特利加压素治疗失代偿期肝硬化并发肝肾综合征患者疗效分析*[J]. 实用肝脏病杂志, 2019, 22(5): 684-687.
[15]	张梅, 石秀英, 李林娟, 薛亚妮. 肝源性糖尿病患者肝组织干扰素诱导蛋白-10表达变化*[J]. 实用肝脏病杂志, 2019, 22(5): 688-691.